Resources
The International Guideline for the Definition, Classification, Diagnosis and Management of Urticaria
https://pubmed.ncbi.nlm.nih.gov/41649409/
Definition, acronyms, nomenclature, and classification of angioedema (DANCE): AAAAI, ACAAI, ACARE, and APAAACI DANCE consensus
https://pubmed.ncbi.nlm.nih.gov/38670233/
Machine learning-assisted diagnosis classification of primary immune dysregulation using IDDA2.1 phenotype profiling
https://pubmed.ncbi.nlm.nih.gov/41202990/
Epidemiology and management of malignancies in patients with inborn errors of immunity-An ESID registry study of 19,959 patients
https://pubmed.ncbi.nlm.nih.gov/41242640/
Expert Recommendations on the Diagnosis of Eosinophilic Esophagitis in the United Arab Emirates
https://pubmed.ncbi.nlm.nih.gov/38618346/
Secondary antibody deficiencies in the modern era: emerging trends, diagnostic pitfalls, and advances in personalised management
https://pubmed.ncbi.nlm.nih.gov/41126828/
Diagnostic Delay in Patients With Chronic Urticaria: Results From the Chronic Urticaria Registry (CURE)
https://pubmed.ncbi.nlm.nih.gov/41532284/
Hereditary Angioedema with Normal C1 Inhibitor: an Updated International Consensus Paper on Diagnosis, Pathophysiology, and Treatment
https://pubmed.ncbi.nlm.nih.gov/40053270/
Consensus on diagnosis and management of Hereditary Angioedema in the Middle East: A Delphi initiative
https://pubmed.ncbi.nlm.nih.gov/36601261/
2025 Inborn errors of immunity practice parameter: Guidance from the Joint Task Force on Practice Parameters, the American Academy of Allergy, Asthma & Immunology (AAAAI), the American College of Allergy, Asthma and Immunology (ACAAI) and the Clinical Immunology Society (CIS)
https://pubmed.ncbi.nlm.nih.gov/41936423/
The 2024 update of IUIS phenotypic classification of human inborn errors of immunity